JCCVS

Journal of Cardiology & Cardiovascular Surgery scientific, open-access, double-blind peer-reviewed journal covering a wide spectrum of topics in cardiology and cardiovascular surgery. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

EndNote Style
Index
Case Report
Renal denervation for resistant hypertension in an elderly patient despite quintuple antihypertensive therapy: a case report
Hypertension is the leading cause of cardiovascular morbidity and mortality. Renal nerves have critical roles in the regulation of blood pressure and fluid volume, and their dysfunction is closely associated with cardiovascular diseases. The denervation procedure is performed through a renal ablation catheter and has been shown in recent trials to provide impressive blood pressure reductions and a favorable safety profile in drug-resistant hypertension. We present a 78-year-old patient who underwent renal denervation due to unresponse to quintuple antihypertensive treatment.


1. Dagdelen S, and Batur MK. “Interventional therapy in resistanthypertension; new renal denervation applications in Turkiye/Direnclihipertansiyonda girisimsel tedavi; Turkiye’deki yeni renal denervasyonuygulamalari.” The Anatolian Journal of Cardiology (AnadoluKardiyoloji Dergisi).2012:12.(2)187-188.
2. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J.Global burden of hypertension: analysis of worldwide data. Lancet. 15-21;365(9455):217-223. doi: 10.1016/S0140-6736(05)17741-1
3. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospectivestudies collaboration. age-specific relevance of usual blood pressure tovascular mortality: a meta-analysis of individual data for one millionadults in 61 prospective studies. Lancet. 2002 Dec 14;360(9349):1903-1913. doi: 10.1016/s0140-6736(02)11911-8
4. Pisano A, Iannone LF, Leo A, Russo E, Coppolino G, Bolignano D.Renal denervation for resistant hypertension. Cochrane Database SystRev. 2021 Nov 22;11(11):CD011499. doi: 10.1002/14651858.CD011499
5. Gupta A, Prince M, Bob-Manuel T, Jenkins JS. Renal denervation:Alternative treatment options for hypertension? Prog Cardiovasc Dis.2020;63(1):51-57. doi: 10.1016/j.pcad.2019.12.007
6. Mahfoud, Felix, et al. “Ambulatory blood pressure changes after renalsympathetic denervation in patients with resistant hypertension.”Circulation 128.2 (2013): 132-140.
7. Kandzari DE, Böhm M, Mahfoud F, et al. “Long-term effects of renalartery denervation on blood pressure and safety in patients withresistant hypertension (SYMPLICITY HTN-3): 3-year follow-up resultsof a randomised controlled trial. The Lancet. 2018:2340-2348
8. Bhatt, Deepak L., et al. “A controlled trial of renal denervation forresistant hypertension.” New England Journal of Medicine 370.15(2014): 1393-1401.
Volume 2, Issue 2, 2024
Page : 36-38
_Footer